Logan B K, Fligner C L, Haddix T
Department of Laboratory Medicine, University of Washington, Seattle 98134, USA.
J Forensic Sci. 1998 Jan;43(1):28-34.
We reviewed a series of deaths in which methamphetamine was detected in the decedent's blood. Analysis of postmortem whole blood was performed by gas chromatography/mass spectrometry with a limit of quantitation of 0.05 mg/L. Methamphetamine was detected in 146 cases; 52 were drug caused, i.e., a death in which the direct toxic effects of the drug caused or contributed to the death, 92 were classified as drug related, i.e., a death in which the drug was demonstrated in the blood, but did not directly cause death. A large proportion of the deaths resulted from homicidal (27%) or suicidal (15%) violence. An examination of methamphetamine concentrations in drug related deaths (n = 92), suggests that the range of concentrations in the recreational abusing population is substantial (0.05-9.30 mg/L) but with a median concentration of 0.42 mg/L, and with 90% of that population having concentrations less than 2.20 mg/L. There was substantial overlap in methamphetamine concentration between drug related deaths and drug caused deaths, although the highest concentrations were seen in the unintentional (accidental or undetermined) drug caused deaths. Methamphetamine related traffic deaths (n = 17) showed patterns of driving behavior consistent with reports elsewhere, and showed blood methamphetamine concentrations ranging from 0.05-2.60 mg/L (median 0.35 mg/L). The data show that most methamphetamine deaths occur with blood concentrations greater than 0.5 mg/L, but can occur with levels as low as 0.05 mg/L, though usually in conjunction with other drugs or significant natural disease. Neither apparently toxic nor therapeutic concentrations should be used in isolation to establish conclusively whether a death was caused by methamphetamine; proper classification of deaths involving methamphetamine requires complete death investigation, including investigation of the scene and circumstances of death, and a complete autopsy.
我们回顾了一系列在死者血液中检测出甲基苯丙胺的死亡案例。通过气相色谱/质谱法对死后全血进行分析,定量限为0.05 mg/L。在146例案例中检测出了甲基苯丙胺;其中52例为药物致死,即药物的直接毒性作用导致或促成了死亡,92例被归类为与药物相关,即血液中检测出了药物,但并非直接导致死亡。很大一部分死亡是由他杀(27%)或自杀(15%)暴力所致。对与药物相关死亡案例(n = 92)中的甲基苯丙胺浓度进行检查发现,娱乐性滥用人群中的浓度范围很大(0.05 - 9.30 mg/L),但中位数浓度为0.42 mg/L,且该人群中90%的浓度低于2.20 mg/L。与药物相关死亡案例和药物致死案例中的甲基苯丙胺浓度有很大重叠,尽管最高浓度出现在非故意(意外或死因不明)药物致死案例中。与甲基苯丙胺相关的交通死亡案例(n = 17)显示出的驾驶行为模式与其他地方的报告一致,血液中甲基苯丙胺浓度范围为0.05 - 2.60 mg/L(中位数0.35 mg/L)。数据表明,大多数甲基苯丙胺致死案例发生时血液浓度高于0.5 mg/L,但浓度低至0.05 mg/L时也可能发生,不过通常是与其他药物或严重的自然疾病同时出现。无论是明显的中毒浓度还是治疗浓度,都不应单独用于最终确定死亡是否由甲基苯丙胺引起;对涉及甲基苯丙胺的死亡进行正确分类需要进行全面的死亡调查,包括对死亡现场和情况的调查以及完整的尸检。